The rise in the prevalence of cancer, adoption of technological advanced treatments, ongoing new product launch, and strategic collaboration, better healthcare facilities are key factors contributing to the high CAGR of the Brachytherapy market during the forecast period.
Market Size – USD 368.8 Million in 2018, Market Growth – CAGR of 4.7% Market Trends– Rise in research and development of efficient products
According to the current analysis of Reports and Data, the global Brachytherapy Market valued at USD 368.8 million in 2018 and is expected to reach USD 531.4 billion by the year 2026, at a CAGR of 4.7%. It is a treatment used for the treatment of malignancy; it is done by placing radioactive material inside the body; it is also called internal radiation. The therapy allows doctors to deliver high doses of radiation to specific parts of the body rather than using conventional forms of radiation therapy where radiation is given outside the body. This process targets the tumor and reduces radiation to the nearby healthy tissue.
According to the reports of WHO, the global cancer burden had estimated to be about 18.1 million new cases and 9.6 million deaths by 2018. According to an estimation around 17 million registered breast cancer in 2017, wherein 10 million had prostate cancer in 2017 across the globe. Due to the rise in technological advancements, R&D investments are likely to propel the growth of the market; also, the increase in healthcare awareness are factors improving market growth. However, side effects obtained by the therapy, and availability of other alternative substitute therapies are the primary restraint to the market. North America had held significant market value in the year 2018, owing to the rise in the prevalence of malignancy, and an increase in the healthcare expenditure, and also government funding for better treatment of tumors.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2640
Further key findings from the report suggest
Key companies operating in the market include:
Eckert & Ziegler BEBIG, IsoRay Medical, Inc., Carl Zeiss Meditec AG, Argon Medical Devices Inc., Panacea Medical Technologies, Elekta AB, Boston Scientific Corporation, CR Bard Inc., GE Healthcare, and Varian Medical Systems, Inc
The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2640
The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global Brachytherapy market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.
On basis of product types and application offered by the Brachytherapy industry, the market is segmented into:
End Use Outlook
The regional analysis covers:
To know more about the report @ https://www.reportsanddata.com/report-detail/brachytherapy-market
Benefits of Brachytherapy Market Report:
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2640
Thank you for reading our report. For customization or further inquiry, please get in touch with us. Our team will ensure the report is tailored according to your requirements.
Browse More Reports :
Head of Business Development
Direct Line: +1-212-710-1370
Reports and Data | Web:www.reportsanddata.com